Mereo BioPharma Group plc
NASDAQ:MREOBiotechnology
+$0.03 today
- Market cap
- $51.08M
- Beta
- 0.28
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$0.22
Volume 1.26M
Average 3.36M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Mereo BioPharma Group plc
NASDAQ:MREO
Intrinsic Alpha fair value
Locked
Current Price
$0.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +179.9% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +179.9% (5yr), giving you a quick read on expected growth from here.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Candel Therapeutics, Inc. NASDAQ:CADL | $807.44M | $11.02 | Not rated | -9.2 | +16.88% |
Silence Therapeutics plc NASDAQ:SLN | $528.08M | $11.18 | Not rated | -3.9 | +193.33% |
Capricor Therapeutics, Inc. NASDAQ:CAPR | $480.79M | $8.36 | Not rated | -13.9 | +49.11% |
Contineum Therapeutics, Inc. Class A Common Stock NASDAQ:CTNM | $472.52M | $12.56 | Not rated | -7.5 | -17.03% |
Kyverna Therapeutics, Inc. NASDAQ:KYTX | $414.02M | $6.81 | Not rated | -3.1 | -39.97% |
Lexeo Therapeutics, Inc. Common Stock NASDAQ:LXEO | $259.91M | $3.31 | Not rated | -4.6 | -68.90% |
AC Immune S.A. NASDAQ:ACIU | $256.47M | $2.52 | Not rated | -2.9 | -30.82% |
ProQR Therapeutics N.V. NASDAQ:PRQR | $173.76M | $1.65 | Not rated | -3.8 | -44.71% |
Aldeyra Therapeutics, Inc. NASDAQ:ALDX | $72.69M | $1.21 | Not rated | -4.2 | -81.67% |
Immutep Limited NASDAQ:IMMP | $38.83M | $0.26 | Not rated | -0.9 | -78.67% |
Continue the stock analysis
Jump to another research area for this company.